Rhythm Pharmaceuticals Inc. (RYTM) on Friday announced the appointment of Kim Popovits to its board of directors.
Popovits will join the board, while existing director Ed Mathers will depart.
The company said Mathers has served on the board since 2013.
On Thursday, Rhythm Pharma closed trading 2.08% lesser at $86.29 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.